These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 15650504)

  • 1. Intramuscular ziprasidone for acute agitation in adolescents.
    Hazaray E; Ehret J; Posey DJ; Petti TA; McDougle CJ
    J Child Adolesc Psychopharmacol; 2004; 14(3):464-70. PubMed ID: 15650504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A naturalistic evaluation of intramuscular ziprasidone versus intramuscular olanzapine for the management of acute agitation and aggression in children and adolescents.
    Khan SS; Mican LM
    J Child Adolesc Psychopharmacol; 2006 Dec; 16(6):671-7. PubMed ID: 17201611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intramuscular ziprasidone in youth: a retrospective chart review.
    Staller JA
    J Child Adolesc Psychopharmacol; 2004; 14(4):590-2. PubMed ID: 15662151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agitation and/or aggression after traumatic brain injury in the pediatric population treated with ziprasidone. Clinical article.
    Scott LK; Green R; McCarthy PJ; Conrad SA
    J Neurosurg Pediatr; 2009 Jun; 3(6):484-7. PubMed ID: 19485732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naturalistic study of intramuscular ziprasidone versus conventional agents in agitated elderly patients: retrospective findings from a psychiatric emergency service.
    Kohen I; Preval H; Southard R; Francis A
    Am J Geriatr Pharmacother; 2005 Dec; 3(4):240-5. PubMed ID: 16503319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A retrospective chart review of intramuscular ziprasidone for agitation in children and adolescents on psychiatric units: prospective studies are needed.
    Barzman DH; DelBello MP; Forrester JJ; Keck PE; Strakowski SM
    J Child Adolesc Psychopharmacol; 2007 Aug; 17(4):503-9. PubMed ID: 17822344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intramuscular Ziprasidone Dosing for Acute Agitation in the Pediatric Emergency Department: An Observational Study.
    Nguyen T; Stanton J; Foster R
    J Pharm Pract; 2018 Feb; 31(1):18-21. PubMed ID: 28205446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discontinuing the Use of PRN Intramuscular Medication for Agitation in an Acute Psychiatric Hospital.
    Hayes A; Russ MJ
    Psychiatr Q; 2016 Mar; 87(1):25-9. PubMed ID: 25869884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid-acting IM ziprasidone in a psychiatric emergency service: a naturalistic study.
    Preval H; Klotz SG; Southard R; Francis A
    Gen Hosp Psychiatry; 2005; 27(2):140-4. PubMed ID: 15763126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intramuscular ziprasidone: an effective agent for sedation of the agitated ED patient.
    Fulton JA; Axelband J; Jacoby JL; Heller MB
    Am J Emerg Med; 2006 Mar; 24(2):254-5. PubMed ID: 16490666
    [No Abstract]   [Full Text] [Related]  

  • 11. Intramuscular ziprasidone: moving beyond the conventional in the treatment of acute agitation in schizophrenia.
    Brook S
    J Clin Psychiatry; 2003; 64 Suppl 19():13-8. PubMed ID: 14728085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intramuscular ziprasidone: influence of alcohol and benzodiazepines on vital signs in the emergency setting.
    Wilson MP; MacDonald K; Vilke GM; Ronquillo L; Feifel D
    J Emerg Med; 2013 Dec; 45(6):901-8. PubMed ID: 24071032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Parenteral Antipsychotics in the Treatment of Agitation and Aggression].
    Utzerath G; Reske D; Gouzoulis-Mayfrank E
    Fortschr Neurol Psychiatr; 2015 Dec; 83(12):665-75. PubMed ID: 26714248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parenteral ziprasidone: a new atypical neuroleptic for emergency treatment of psychosis in Parkinson's disease?
    Oechsner M; Korchounov A
    Hum Psychopharmacol; 2005 Apr; 20(3):203-5. PubMed ID: 15799011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New treatments for agitation.
    Citrome L
    Psychiatr Q; 2004; 75(3):197-213. PubMed ID: 15335224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transition from ziprasidone im to oral formulation in agitated patients with acute exacerbation of schizophrenia: an open trial.
    Mautone A; Scarone S;
    Pharmacopsychiatry; 2011 Jul; 44(5):173-8. PubMed ID: 21751127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case series: use of ziprasidone for maladaptive symptoms in youths with autism.
    McDougle CJ; Kem DL; Posey DJ
    J Am Acad Child Adolesc Psychiatry; 2002 Aug; 41(8):921-7. PubMed ID: 12164181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of agitation in mental illness: treatment guidelines and current therapies.
    Marder SR
    J Clin Psychiatry; 2006; 67 Suppl 10():13-21. PubMed ID: 16965191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A retrospective study exploring the effects of intramuscular aripiprazole on QTc change in agitated medically ill patients.
    Muzyk AJ; Rivelli SK; Gagliardi JP; Revollo JY; Jiang W
    J Clin Psychopharmacol; 2011 Aug; 31(4):532-4. PubMed ID: 21720229
    [No Abstract]   [Full Text] [Related]  

  • 20. A trial of lithium citrate for the management of acute agitation of psychiatric inpatients: a pilot study.
    Lee HK; Reddy TB; Travin S; Bluestone H
    J Clin Psychopharmacol; 1992 Oct; 12(5):361-2. PubMed ID: 1479057
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.